Eric Blasius Risser - 04 Mar 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: Chief Operating Officer
Signature: /s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol: MGNX
Transactions as of: 04 Mar 2022
Net transactions value: +$470
Form type: 4
Filing time: 04 Mar 2022, 16:45:22 UTC
Previous filing: 24 Feb 2022
Next filing: 31 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Options Exercise	$470	+500	+1.1%	$0.9400^*	44,968	04 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Employee stock option (right to buy)	Options Exercise	$0	-500	-100%	$0.000000^*	0	04 Mar 2022	Common Stock	500	$0.9400	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.